A recent study demonstrated the usage of α-synuclein concentration in plasma EVs to discriminate between PD, healthy controls, and atypical PD, such as dementia with Lewy bodies or progressive supranuclear palsy [69]. Here, SNCA is linked to Parkinson disease.